Product: Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged in a) single dose vial (NDC 0703-6801-01), b) 25-count box single dose vials (NDC 0703-6801-04), Rx only, MFG: Teva Pharma USA
Reason for recall: cGMP deviations: Temperature abuse
Recall initiated: 20220413
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated